Loading…

Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2

[...]all humans lack the αGal glycan motif and possess natural anti-αGal antibodies generated in response to bacteria of the microbiota that express similar glycans [2]. [...]blood group O individuals were at a much lower risk of being infected than non-O individuals in a Hong Kong 2003 SARS hospita...

Full description

Saved in:
Bibliographic Details
Published in:PLoS pathogens 2020-05, Vol.16 (5), p.e1008556-e1008556
Main Authors: Breiman, Adrien, Ruvën-Clouet, Nathalie, Le Pendu, Jacques
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]all humans lack the αGal glycan motif and possess natural anti-αGal antibodies generated in response to bacteria of the microbiota that express similar glycans [2]. [...]blood group O individuals were at a much lower risk of being infected than non-O individuals in a Hong Kong 2003 SARS hospital outbreak [15], and a similar trend has just been observed for COVID-19 in China [16]. [...]blood group O individuals would be at a lesser risk of being infected than non-O individuals due to blocking of potential transmission events from either A, B, or AB individuals, providing anti-A or anti-B titers are of sufficient magnitude (Fig 1). In the presence of high-titered anti-A and anti-B antibodies, transmissions represented by dashed arrows should be completely ablated. https://doi.org/10.1371/journal.ppat.1008556.g001 We therefore hypothesize that as they are produced in cells coexpressing the ACE2 receptor and either the αGal, NeuGc, or A/B blood group antigens, both SARS-CoV and SARS-CoV2 harbor the corresponding glycan epitopes. Because of the natural immune response against these epitopes, the αGal and NeuGc xenoantigens would contribute to prevent cross-species transmission from nonprimate mammals to humans, while A/B blood group antigens would contribute to decrease and slow between-human transmission.
ISSN:1553-7374
1553-7366
1553-7374
DOI:10.1371/journal.ppat.1008556